why is my tirzepatide red spot from injection Let me take you along for weekly injection. This week Thought I would ask before

Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks

Its baseline scale is rooted in the rising global prevalence of type 2 diabetes

Is this enough evidence to change treatment on its own

While regulation of iron metabolism-related proteins or the use of iron chelators can reduce intracellular labile Fe 2+ levels and inhibit ferroptosis, current chelators lack tissue and cellular specificity and may interfere with neurophysiological functions, thereby limiting their clinical applicability

16 This change is supported by findings from the 2024 STEP-HFpEF DM trial